Hemorrhage is the leading cause of death in civilian and military trauma. Fortunately, there is hope. Through the Joint Theater Trauma System, which is an organized approach to providing improved ...

Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued Tranexamic acid reduces risk of death and thrombotic events in patients with traumatic bleeding, irrespective of the baseline risk of ...

Please provide your email address to receive an email when new articles are posted on . Tranexamic acid may be indicated for the prevention of heterotopic ossification. Patients undergoing surgery for ...

A systematic review and meta-analysis show that tranexamic acid for bleeding significantly lowers mortality at 1 month after traumatic injury and traumatic brain injury, according to a new study in ...

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common ...

Researchers from Osaka University use machine learning to identify patients more likely to survive traumatic injury if treated with tranexamic acid. Worldwide, approximately 4.5 million people die of ...

For suspected severe traumatic brain injury (TBI), giving tranexamic acid to limit internal brain bleeding before trauma center arrival appeared safe -- except in those without evidence of ...

Tranexamic acid (TXA) (multiple brands), an antifibrinolytic used to treat or prevent excessive blood loss, significantly reduces mortality from traumatic brain injury (TBI), results of a large, ...

This paper is geared toward the Department of Defense medical community, in particular, the U.S. Army Medical Command (USAMEDCOM), and advocates for the widespread adoption of tranexamic acid (TXA) ...

Rafa Laboratories has received a potential $186 million contract from the Biomedical Advanced Research and Development Authority to develop an intramuscular formulation of tranexamic acid, or IM TXA, ...